Efficacy and Safety Study With Visonac Photodynamic Therapy (PDT)

PHASE2CompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Acne Vulgaris
Interventions
DRUG

Visonac PDT (MAL PDT)

Cream application followed by illumination with red light.

DRUG

Vehicle cream (placebo)

Cream application followed by illumination with red light.

PROCEDURE

PDT

Photodynamic Therapy - Light dose 37 J/cm2

Trial Locations (11)

2880

Centre de Recherche Dermatologique, Québec

14623

Dermatology Associates of Rochester, Rochester

17033

Milton S. Hershey Medical Center, Hershey

23507

Virginia Clinical Research, Inc., Norfolk

53719

Madison Skin & Research, Inc, Madison

55432

Minnesota Clinical Study Center, Fridley

60563

Dermatology Institute of DuPage Medical Group, Naperville

60611

DeNova Research, Chicago

92123

Children's Specialists of San Diego / Rady Children's Hospital San Diego, San Diego

N8W 5L7

Windsor Clinical Research, Inc., Windsor, Ontario N8W 5L7

Unknown

INNOVADERM Research Inc., Montreal

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Photocure

INDUSTRY